Dr. Benjamin Schlechter on Botensilimab: Practice-changing Drug | Most Promising Cancer Drugs 2024

In this episode of OncoDaily, Dr. Benjamin Schlechter, a distinguished medical oncologist at the Dana-Farber Cancer Institute, joins host Amalya Sargsyan to discuss Botensilimab, a next-generation anti-CTLA-4 therapy for immunotherapy. Dr. Schlechter shares his involvement in trials, highlighting the drug's innovation in overcoming resistance in immune therapies, particularly in MSS colorectal cancer. He emphasizes the drug's potential as a practice-changing treatment and provides insights into its safety profile and future applications in oncology.
‪@danafarber‬

#Cancer #Botensilimab #Agenus #OncoDaily #ClinicalTrials #CancerResearch #Immunotherapy #CTLA4 #Oncology #CancerTreatment #ColorectalCancer #ColorectalCancer #CancerSurvivorship #CancerInnovation #MedicalOncology #CancerCare #CancerBreakthroughs #PrecisionMedicine #CancerExperts #CancerAwareness

00:00 Recap
01:45 Introduction
02:26 GI Oncology Journey
03:55 Colon Cancer Breakthrough
06:16 Managing Immunotherapy Side Effects
09:33 Challenges in Phase 1 Trials
11:13 Revolutionizing Colorectal Cancer
12:35 Practice-Changing Immune Therapy
13:56 Addressing Liver Metastases
14:46 Exploring Optimal Drug Use
16:00 Accelerating Trial Enrollment
18:34 Conclusion

SUBSCRIBE to get the latest #oncodaily    / @oncodailytv  

Visit the OncoDaily Website : https://oncodaily.com
Like OncoDaily on LinkedIn:   / oncodaily  
Like OncoDaily on X (Twitter): https://x.com/oncodaily
Follow OncoDaily on Instagram:   / oncodailynews  
Follow OncoDaily on TikTok:   / oncodaily  
Like OncoDaily on Facebook:   / oncodaily  

SUBSCRIBE to OncoDaily Newsletter: https://oncodaily.com/submit-newsletter

About OncoDaily
OncoDaily is a world-leading oncology media platform, which is based in the United States and features the cancer related latest news, insights, and patient stories from around the globe. The mission of OncoDaily is to empower patients, survivors, and professionals with the knowledge and inspiration they need to fight cancer. The motto of OncoDaily is “Cancer doesn’t take a day off – neither do we.”